222 related articles for article (PubMed ID: 31648561)
1. KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction
Zhou L; Li Q; Chen A; Liu N; Chen N; Chen X; Zhu L; Xia B; Gong Y; Chen X
FASEB J; 2019 Dec; 33(12):14254-14269. PubMed ID: 31648561
[TBL] [Abstract][Full Text] [Related]
2. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
[TBL] [Abstract][Full Text] [Related]
3. The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes.
Zhang Y; Lei T; Huang JF; Wang SB; Zhou LL; Yang ZQ; Chen XD
Mol Cell Endocrinol; 2011 Aug; 342(1-2):41-7. PubMed ID: 21664250
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis.
Jiang S; Yan C; Fang QC; Shao ML; Zhang YL; Liu Y; Deng YP; Shan B; Liu JQ; Li HT; Yang L; Zhou J; Dai Z; Liu Y; Jia WP
J Biol Chem; 2014 Oct; 289(43):29751-65. PubMed ID: 25170079
[TBL] [Abstract][Full Text] [Related]
5. TWIST2 inhibits EMT and induces oxidative stress in lung cancer cells by regulating the FGF21-mediated AMPK/mTOR pathway.
Song Y; Zhang W; Zhang J; You Z; Hu T; Shao G; Zhang Z; Xu Z; Yu X
Exp Cell Res; 2021 Aug; 405(1):112661. PubMed ID: 34044016
[TBL] [Abstract][Full Text] [Related]
6. Palmitoleate induces hepatic steatosis but suppresses liver inflammatory response in mice.
Guo X; Li H; Xu H; Halim V; Zhang W; Wang H; Ong KT; Woo SL; Walzem RL; Mashek DG; Dong H; Lu F; Wei L; Huo Y; Wu C
PLoS One; 2012; 7(6):e39286. PubMed ID: 22768070
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-specific deletion of BAP31 promotes SREBP1C activation, promotes hepatic lipid accumulation, and worsens IR in mice.
Xu JL; Li LY; Wang YQ; Li YQ; Shan M; Sun SZ; Yu Y; Wang B
J Lipid Res; 2018 Jan; 59(1):35-47. PubMed ID: 29113994
[TBL] [Abstract][Full Text] [Related]
8. Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c.
Lee YS; Lee HH; Park J; Yoo EJ; Glackin CA; Choi YI; Jeon SH; Seong RH; Park SD; Kim JB
Nucleic Acids Res; 2003 Dec; 31(24):7165-74. PubMed ID: 14654692
[TBL] [Abstract][Full Text] [Related]
9. B-cell translocation gene 2 enhances fibroblast growth factor 21 production by inducing Kruppel-like factor 15.
Kim YD; Hwang SL; Jeon HJ; Jeon YH; Nedumaran B; Kim K; Lee SE
Sci Rep; 2019 Mar; 9(1):3730. PubMed ID: 30842568
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.
Marino JS; Stechschulte LA; Stec DE; Nestor-Kalinoski A; Coleman S; Hinds TD
J Biol Chem; 2016 Dec; 291(50):25776-25788. PubMed ID: 27784782
[TBL] [Abstract][Full Text] [Related]
11. RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.
Cui XB; Luan JN; Chen SY
J Biol Chem; 2015 Aug; 290(33):20387-95. PubMed ID: 26134570
[TBL] [Abstract][Full Text] [Related]
12. TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis.
Zhang Y; Ge X; Li Y; Zhang B; Wang P; Hao M; Gao P; Zhao Y; Sun T; Lu S; Ma W
Lipids Health Dis; 2021 Apr; 20(1):39. PubMed ID: 33879188
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway.
Wu YK; Ren ZN; Zhu SL; Wu YZ; Wang G; Zhang H; Chen W; He Z; Ye XL; Zhai QX
Acta Pharmacol Sin; 2022 Jun; 43(6):1473-1483. PubMed ID: 34654875
[TBL] [Abstract][Full Text] [Related]
14. Prevention and reversal of hepatic steatosis with a high-protein diet in mice.
Garcia-Caraballo SC; Comhair TM; Verheyen F; Gaemers I; Schaap FG; Houten SM; Hakvoort TB; Dejong CH; Lamers WH; Koehler SE
Biochim Biophys Acta; 2013 May; 1832(5):685-95. PubMed ID: 23410526
[TBL] [Abstract][Full Text] [Related]
15. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
16. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
18.
Long X; Liu D; Gao Q; Ni J; Qian L; Ni Y; Fang Q; Jia W; Li H
Front Endocrinol (Lausanne); 2021; 12():773340. PubMed ID: 35035378
[TBL] [Abstract][Full Text] [Related]
19. Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes.
Li N; Li M; Hong W; Shao J; Xu H; Shimano H; Lu J; Xu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2881-2889. PubMed ID: 29857051
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl fumarate reduces oxidative stress, inflammation and fat deposition by modulation of Nrf2, SREBP-1c and NF-κB signaling in HFD fed mice.
Vanani AR; Kalantari H; Mahdavinia M; Rashno M; Khorsandi L; Khodayar MJ
Life Sci; 2021 Oct; 283():119852. PubMed ID: 34332979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
